Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia

Published:2018-02 Issue:2 Volume:40 Page:158-167
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Salem Mohamed Labib¹²^ORCID,El-Shanshory Mohamed R.¹³^ORCID,Abdou Said H.¹⁴^ORCID,Attia Mohamed S.¹⁴,Sobhy Shymaa M.¹²^ORCID,Zidan Mona F.¹²^ORCID,Zidan Abdel-Aziz A.¹⁵^ORCID

Affiliation:

1. Center of Excellence in Cancer Research (CECR), Tanta University, Tanta, Egypt;

2. Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt;

3. Pediatric Oncology, Faculty of Medicine, Tanta University, Tanta, Egypt;

4. Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt;

5. Department of Zoology, Damanhour University, Damanhour, Egypt

Funder

Science and Technology Development Fund

Ministry of Higher Education and Scientific Research

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2018.1424897

Reference55 articles.

1. Childhood B-acute lymphoblastic leukemia: a genetic update

2. Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

3. Relapsed acute lymphoblastic leukemia with unusual multiple bone invasions: A case report

4. Quantitative Expression of TEL in Childhood Acute Lymphoblastic Leukemia

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges;Cancers;2024-06-12

2. Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study;IRAN J IMMUNOL;2024

3. Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics;Frontiers in Immunology;2024-01-17

4. Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers;Frontiers in Oncology;2023-12-01

5. Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2023-08-01